GFAP and amyotrophic lateral sclerosis: S100β silencing in SOD1G93A astrocytes determined the down-regulation of GFAP, TNF-α, C-X-C motif chemokine 10 and Chemokine (C-C motif) ligand 6 expression, ameliorating the reactive pro-inflammatory phenotype of ALS astrocytes [96].